|
|
|
Insider
Information: |
Troendle August J. |
Relationship: |
CEO, Director, 10% Owner |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
694,387 |
|
Indirect Shares
|
6,643,939 |
|
|
Direct
Value |
$259,056,967 |
|
|
Indirect Value
|
$1,849,057,508 |
|
|
Total
Shares |
7,338,326 |
|
|
Total
Value |
$2,108,114,474 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
36
|
Stock
price went up :
|
0
|
19
|
Stock
price went down : |
0
|
17
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.1
|
Percentage
Gain/Loss : |
0.0%
|
480.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Coherus Biosciences, Inc. |
CHRS |
Director |
2016-02-09 |
29,994 |
2016-02-09 |
1,910,920 |
Premium* |
|
Medpace Holdings, Inc. |
MEDP |
CEO, Director, 10% Owner |
2024-05-20 |
664,393 |
2024-05-20 |
4,733,019 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
228 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2021-12-27 |
4 |
AS |
$226.11 |
$8,856,955 |
I/I |
(39,171) |
5,577,414 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-22 |
4 |
AB |
$154.59 |
$8,877,485 |
I/I |
57,426 |
6,483,019 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-08 |
4 |
AB |
$157.65 |
$8,916,211 |
I/I |
56,557 |
5,774,100 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-03-01 |
4 |
OE |
$90.65 |
$9,065,000 |
D/D |
100,000 |
806,643 |
0 |
- |
|
MEDP |
Medpace Holdings, Inc. |
President & CEO |
|
2018-08-06 |
4 |
AS |
$58.51 |
$9,149,150 |
D/D |
(156,369) |
489,956 |
0 |
- |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-09 |
4 |
AB |
$164.33 |
$9,294,012 |
I/I |
56,557 |
5,830,657 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-16 |
4 |
AB |
$149.58 |
$9,351,143 |
I/I |
62,516 |
6,143,236 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2023-11-15 |
4 |
S |
$283.42 |
$9,352,860 |
I/I |
(33,000) |
5,856,947 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-14 |
4 |
AB |
$152.66 |
$9,543,693 |
I/I |
62,516 |
6,018,204 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-15 |
4 |
AB |
$153.11 |
$9,571,825 |
I/I |
62,516 |
6,080,720 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2024-05-06 |
4 |
S |
$401.73 |
$9,790,964 |
D/D |
(24,372) |
749,011 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-13 |
4 |
AB |
$157.12 |
$9,822,514 |
I/I |
62,516 |
5,955,688 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2024-03-08 |
4 |
S |
$408.71 |
$10,217,750 |
I/I |
(25,000) |
4,733,019 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2022-09-12 |
4 |
AB |
$167.58 |
$10,476,264 |
I/I |
62,515 |
5,893,172 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2021-11-22 |
4 |
AS |
$224.33 |
$10,796,554 |
I/I |
(48,128) |
5,909,074 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2023-06-08 |
4 |
AS |
$220.85 |
$10,898,285 |
I/I |
(49,347) |
6,233,019 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2024-05-07 |
4 |
S |
$404.48 |
$11,338,383 |
D/D |
(28,032) |
720,979 |
0 |
% |
|
CHRS |
Coherus Biosciences, Inc. |
Director |
|
2015-07-30 |
4 |
AS |
$32.22 |
$11,504,564 |
I/I |
(340,000) |
268,428 |
0 |
- |
|
MEDP |
Medpace Holdings, Inc. |
President & CEO |
|
2018-08-03 |
4 |
AS |
$59.94 |
$12,185,562 |
D/D |
(203,296) |
646,325 |
0 |
- |
|
MEDP |
Medpace Holdings, Inc. |
President & CEO |
|
2021-01-06 |
4 |
AS |
$140.06 |
$12,838,880 |
I/I |
(91,667) |
6,577,420 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2023-06-06 |
4 |
AS |
$220.46 |
$12,936,813 |
I/I |
(58,681) |
6,392,690 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2024-05-15 |
4 |
S |
$405.13 |
$13,078,407 |
D/D |
(32,282) |
675,473 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
President & CEO |
|
2021-01-07 |
4 |
AS |
$140.06 |
$13,102,893 |
I/I |
(93,552) |
6,483,868 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2023-11-17 |
4 |
S |
$273.91 |
$13,695,500 |
I/I |
(50,000) |
5,789,947 |
0 |
% |
|
MEDP |
Medpace Holdings, Inc. |
CEO |
|
2023-11-20 |
4 |
S |
$275.45 |
$13,772,500 |
I/I |
(50,000) |
5,739,947 |
0 |
% |
|
228 Records found
|
|
Page 8 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|